(Q28204246)

1

0 references

Thomas B Stanley

2

0 references

Richard Hazen

3

0 references

Edward P Garvey

Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex

4

0 references

language of work or name

English

0 references

publication date

June 2002

0 references

published in

Antiviral Research

0 references

volume

54

0 references

issue

3

0 references

page(s)

149-62

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Solution oligomerization of the rev protein of HIV-1: implications for function.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

The Molecular Weight of Avidin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

The ins and outs of HIV Rev.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Recognition of the high affinity binding site in rev-response element RNA by the Human Immunodeficiency Virus type-1 rev protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

A computer screening approach to immunoglobulin superfamily structures and interactions: discovery of small non-peptidic CD4 inhibitors as novel immunotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

A molecular rheostat. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type-1 late gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Mimicking dominant negative inhibition of prion replication through structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Incidence and impact of resistance against approved antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Binding site of brefeldin A at the interface between the small G protein ADP-ribosylation factor 1 (ARF1) and the nucleotide-exchange factor Sec7 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Inhibition of HIV replication by immunoliposomal antisense oligonucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Construction of a cell-based high-flux assay for the rev protein of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Real-time kinetics of HIV-1 Rev-Rev response element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Antiretroviral therapy: state of the HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021

Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900222-4

7 January 2021